Cargando…
Ranibizumab treatment history as predictor of the switch-response to aflibercept: evidence for drug tolerance
PURPOSE: To investigate whether tolerance to the anti-VEGF drug, ranibizumab, develops after drug exposure and to determine whether the history of treatment with ranibizumab prior to refractoriness can predict the post-switching responses to aflibercept. METHODS: We retrospectively investigated neov...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880512/ https://www.ncbi.nlm.nih.gov/pubmed/29636594 http://dx.doi.org/10.2147/OPTH.S160367 |